Molecular Future is a China-based biotech company that develops analytical tools and software for drug discovery and diagnostics.
Founded in 2017 in China, Molecular Future Limited develops molecular analysis tools, including high-throughput screening systems, analysis software and reagents used in drug discovery and diagnostics. Its founders are Jason Tso and Jayden Wei. The company received CNY 25 million from investor China Fortune in March 2018, which is its total fundraising to date. It plans to expand its market presence in Europe and Asia-Pacific by 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in